These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26547594)

  • 21. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
    Hermansyah A; Sainsbury E; Krass I
    Res Social Adm Pharm; 2017; 13(4):727-737. PubMed ID: 27530306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consumer willingness to pay for pharmacy services: An updated review of the literature.
    Painter JT; Gressler L; Kathe N; Slabaugh SL; Blumenschein K
    Res Social Adm Pharm; 2018 Dec; 14(12):1091-1105. PubMed ID: 29398405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A needs assessment of community pharmacists for pharmacist specialization in Canada.
    Jorgenson D; Penm J; MacKinnon N; Smith J
    Int J Pharm Pract; 2017 Apr; 25(2):159-167. PubMed ID: 27488476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care.
    Okoro RN
    Res Social Adm Pharm; 2021 Jan; 17(1):1925-1928. PubMed ID: 33317766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model.
    Sabater-Galindo M; Ruiz de Maya S; Benrimoj SI; Gastelurrutia MA; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(2):313-320. PubMed ID: 27185270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacists' experience of conflict in community practice.
    Austin Z; Gregory PA; Martin JC
    Res Social Adm Pharm; 2010 Mar; 6(1):39-48. PubMed ID: 20188327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal.
    Amariles P; Ledezma-Morales M; Salazar-Ospina A; Hincapié-García JA
    Res Social Adm Pharm; 2021 Jan; 17(1):1988-1989. PubMed ID: 32224133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Pharmacists as Immunizers in North Carolina.
    Trotta K
    N C Med J; 2017; 78(3):206-207. PubMed ID: 28576964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.
    Sherman EM; Elrod S; Allen D; Eckardt P
    J Pharm Pract; 2014 Dec; 27(6):578-81. PubMed ID: 24326407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing pharmacists' role as oral health advisors.
    Cohen LA
    J Am Pharm Assoc (2003); 2013; 53(3):316-21. PubMed ID: 23699681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community pharmacists preventing hospital readmissions.
    Clay PG
    J Am Pharm Assoc (2003); 2014; 54(2):208. PubMed ID: 24632935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.